
Oxford Science Enterprises (OSE) is an independent venture capital firm that partners with the University of Oxford to found, fund, and build transformational businesses based on university research across life sciences, health tech, and deep technology. Originally established as Oxford Sciences Innovation, it was rebranded to Oxford Science Enterprises.
Deal activity increased 140% year-over-year (12 deals in the last 12 months). Average disclosed round size is $39.9M (across 86 rounds with reported amounts).
Portfolio
95
Fund Size
—
Top Stage
Series A
Last 12 Mo
12
Team
Claire Brown
Partner, Life Sciences
Heather Roxborough
Senior Partner, Head of HealthTech
Katherine Ward
Operating Partner, HealthTech
Katya Smirnyagina
Senior Partner, Head of Life Sciences
Lilly Bussmann
Partner
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| Seed | — | Sep 2026 | |
| Series B | $220M | Sep 2026 | |
| Series A | $115M | Jun 2026 | |
| Series C | — | Jun 2026 | |
| Series B | — | May 2026 | |
| Series D | — | Mar 2026 | |
| SStateful | Pre-Seed | $4.8M | Mar 2026 |
| AAllos | Seed | $5M | Jan 2026 |
| Series C | — | Jan 2026 | |
| Series A | $115M | Jan 2026 | |
| Series A | $22.5M | Jan 2026 | |
| Series C | — | Jan 2026 | |
| Seed | $4M | Jan 2026 | |
| Seed | $5M | Jan 2026 | |
| Unknown | $5.4M | Jan 2026 | |
| Series C | $160M | Jan 2026 | |
| Seed | $12M | Nov 2025 | |
| Seed | $12M | Nov 2025 | |
| Series A | $11.8M | Oct 2025 | |
| Series A | — | Oct 2025 | |
| Seed | $5.6M | Oct 2025 | |
| Series C | $55M | Jul 2025 | |
| Seed | — | May 2025 | |
| Unknown | $15.2M | Mar 2025 | |
| Series A | $30M | Feb 2025 |
Top Co-Investors
Last updated: 7 October 2026